Approval should come within 1/2 a year and then all will be singing EDAPs praises. The market is premtive and all the resource shows that HIFU for prostate cancer not only work but in most cases is better than any surgery. A lot of people with prostate cancer are just told to wait it out and soon, in the US, they will have a much better option.
It could be $10 by the end of Feb pal! I really cannot understand why it hasnt gone parabolic already- maybe its because US investors don't get excited about disruptive technologies not invented by US companies?
This seems a truly different way of treating prostrate cancer. DNDN produced a great drug with impressive survival data but has failed to become a hot stock. what is it with biotech investors and prostrat focussed companies?